Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Winkle

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Circulation|August 1, 1981
Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmiasR A Winkle, F Peters, R E Kates, et al.
American Heart Journal|January 1, 1985
Treatment with oral lorcainide in patients with sustained ventricular tachycardia and fibrillationD S Echt, M Shapiro, J Trusso, et al.
Sleep|October 1, 1989
The diurnal variability of ventricular premature depolarizations: influence of heart rate, sleep, and wakefulnessA M Gillis, C Guilleminault, M Partinen, et al.
The American Journal of Cardiology|July 1, 1978
Effects of tocainide on ventricular fibrillation threshold. Comparison with lidocaineI Schnittger, J C Griffin, R J Hall, et al.
Circulation|June 1, 1986
Effects of encainide and its metabolites on energy requirements for defibrillationE S Fain, P Dorian, J M Davy, et al.
American Heart Journal|November 1, 1984
Practical aspects of automatic cardioverter/defibrillator implantationR A Winkle, E B Stinson, D S Echt, et al.
Circulation|July 1, 1983
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmiasR N Fogoros, K P Anderson, R A Winkle, et al.
Journal of Cardiovascular Pharmacology|September 1, 1980
Effects of encainide (MJ9067) on the ventricular fibrillation threshold in anesthetized dogsP Jaillon, S de la Rosa, J C Griffin, et al.
The Journal of Clinical Investigation|March 1, 1977
The electrophysiologic effects of quinidine in the transplanted human heartJ W Mason, R A Winkle, A K Rider, et al.
Circulation|September 1, 1983
Clinical pharmacology of propafenoneS J Connolly, R E Kates, C S Lebsack, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Circulation|August 1, 1981
Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmiasR A Winkle, F Peters, R E Kates, et al.
American Heart Journal|January 1, 1985
Treatment with oral lorcainide in patients with sustained ventricular tachycardia and fibrillationD S Echt, M Shapiro, J Trusso, et al.
Sleep|October 1, 1989
The diurnal variability of ventricular premature depolarizations: influence of heart rate, sleep, and wakefulnessA M Gillis, C Guilleminault, M Partinen, et al.
The American Journal of Cardiology|July 1, 1978
Effects of tocainide on ventricular fibrillation threshold. Comparison with lidocaineI Schnittger, J C Griffin, R J Hall, et al.
Circulation|June 1, 1986
Effects of encainide and its metabolites on energy requirements for defibrillationE S Fain, P Dorian, J M Davy, et al.
American Heart Journal|November 1, 1984
Practical aspects of automatic cardioverter/defibrillator implantationR A Winkle, E B Stinson, D S Echt, et al.
Circulation|July 1, 1983
Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmiasR N Fogoros, K P Anderson, R A Winkle, et al.
Journal of Cardiovascular Pharmacology|September 1, 1980
Effects of encainide (MJ9067) on the ventricular fibrillation threshold in anesthetized dogsP Jaillon, S de la Rosa, J C Griffin, et al.
The Journal of Clinical Investigation|March 1, 1977
The electrophysiologic effects of quinidine in the transplanted human heartJ W Mason, R A Winkle, A K Rider, et al.
Circulation|September 1, 1983
Clinical pharmacology of propafenoneS J Connolly, R E Kates, C S Lebsack, et al.
Pageof 14